Perspective on PrEP: Connecting Communities & Clinicians

Released On
October 29, 2021

Expires On
October 29, 2022

Media Type

Completion Time
60 minutes

Infectious Disease, Obstetrics & Gynecology, Primary Care


Scroll to the Bottom of this Information to Begin this Course

This activity is jointly provided by Postgraduate Institute for Medicine and DKBmed, LLC.

Supported by an educational grant from Gilead Sciences, Inc.

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)
  • Nurses — 1.0 Contact Hours

All other healthcare professionals completing this course will be issued a statement of participation.

Target Audience

This activity is designed to meet the educational needs of clinicians currently treating people in the LGBTQ+ community.

Program Overview

We have made tremendous progress in treating HIV, but we still have an epidemic, with about 38,000 new HIV cases identified each year. Learn from expert faculty about how pre-exposure prophylaxis (PrEP) can virtually eliminate HIV, who is eligible for PrEP, and how to monitor patients using PrEP. You will also hear stories from people in the LGBTQ+ community who are currently using PrEP.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Assess eligibility for pre-exposure prophylaxis (PrEP) among patients seen in your practice
  • Identify barriers to initiating and sustaining PrEP and utilize strategies to overcome them
  • Implement monitoring recommendations for PrEP
  • Assess the benefits and considerations for current and emerging PrEP therapies



Alison Agwu, MD, ScM, FAAP, FIDSA

Professor, Adult and Pediatric Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, MD


Justin Alves, RN, ACRN, CARN

Nurse Educator – Office Based Addiction Treatment, Training and Technical Assistance Program
Boston Medical Center
Boston, MA


Deja Cabrera

Community Health Educator and Advocate
San Diego LGBT Community Center
San Diego, CA


Marvin Hanashiro

Community Outreach Coordinator
UC San Diego AntiViral Research Center
San Diego, CA


Fidel Martinez

Columbia University
New York, NY

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and DKBmed, LLC. Postgraduate Institute for Medicine is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education Credit Designation

The Postgraduate Institute for Medicine designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education Credit Designation

The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.

Disclosures of Conflicts of Interest

Allison Agwu, MD, SCM, FAAP, FIDSA

  • Consulting Fees: Gilead Sciences, Inc., Merck & Co., Inc.
  • Contracted Research: Gilead Sciences, Inc., Merck & Co., Inc.

Justin Alves, RN, ACRN, CARN: nothing to disclose.

Deja Cabrera: nothing to disclose.

Marvin Hanashiro: nothing to disclose.

Fidel Martinez: nothing to disclose.

Instructions for Participation and Credit

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:

  1. Read the CME/CE information and faculty disclosures.
  2. Participate in the online activity.
  3. Submit the evaluation form.
Certificates will be emailed to the participant

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Disclosure of Unlabeled Use

Postgraduate Institute for Medicine requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.


This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Contact Information

For CME questions please contact: